Evaluation of Deladumone OB in the suppression of postpartum lactation.
Of 235 patients receiving Deladumone OB, more than 39 per cent complained of breast pain or swelling; 83 per cent were pleased with the medication. Of 215 patients receiving a placebo, more than 82 per cent complained of breast pain or swelling; 67.5 per cent were pleased with the medication.
D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D007775:Lactation Disorders / Q000188:drug therapy / Q000517:prevention & control; D010146:Pain; D010919:Placebos; D011247:Pregnancy; D013739:Testosterone / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use
D004338:Drug Combinations; D010919:Placebos; D014631:Valerates; D013739:Testosterone; D004958:Estradiol